sellWeak cluster of 510b5-1 plan
Brophy Michael Burkes sold $128k of NTRA
CHIEF FINANCIAL OFFICER at Natera, Inc.. 1,062 shares at an average of $120.46, traded Oct 21, 2024, filed Oct 22, 2024.
Warning score
13Value
$128k
1,062 shares
Holdings after
73,560
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-025539, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 20, 2024 | MOption exercise Common Stock10b5-1 | +1,522 | - | - | 73,477 | Oct 22, 2024 |
| Oct 21, 2024 | MOption exercise Common Stock10b5-1 | +1,145 | - | - | 74,622 | Oct 22, 2024 |
| Oct 21, 2024 | SOpen-market sale Common Stock10b5-1 | -608 | $120.76 | $73k | 74,014 | Oct 22, 2024 |
| Oct 22, 2024 | SOpen-market sale Common Stock10b5-1 | -454 | $120.07 | $55k | 73,560 | Oct 22, 2024 |
| Oct 20, 2024 | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,522 | $0.00 | $0 | 7,609 | Oct 22, 2024 |
| Oct 21, 2024 | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,145 | $0.00 | $0 | 1,145 | Oct 22, 2024 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell 510b5-1 | NTRA Natera, Inc. | Fesko John PRESIDENT, CHIEF BUS. OFFICER | $107k | 669 | |
| 31Weak | sell 510b5-1 | NTRA Natera, Inc. | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | $388k | 2,428 | |
| 34Weak | sell 510b5-1 | NTRA Natera, Inc. | Sheena Jonathan director, other | $953k | 5,700 | |
| 40Moderate | sell 610b5-1 | NTRA Natera, Inc. | Rabinowitz Matthew EXECUTIVE CHAIRMAN | $27M | 160,000 | |
| 49Moderate | sell 6 | NTRA Natera, Inc. | Chapman Rowan E director | $301k | 1,767 | |
| 22Weak | sell 610b5-1 | NTRA Natera, Inc. | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | $809k | 4,858 | |
| 55Moderate | sell 5 | NTRA Natera, Inc. | BOTHA ROELOF director | $15M | 87,473 | |
| 35Weak | sell 710b5-1 | NTRA Natera, Inc. | Rabinowitz Matthew EXECUTIVE CHAIRMAN | $665k | 4,000 | |
| 65Notable | sell 6 | NTRA Natera, Inc. | Marcus Gail Boxer director | $1.5M | 9,682 | |
| 40Moderate | sell 510b5-1 | NTRA Natera, Inc. | Baynes Roy D. director | $5.4M | 37,230 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.